晚期慢性肾脏病老年患者中CKD-MBD与死亡率的关联:EQUAL研究结果
研究基于EQUAL研究纳入1294例≥65岁、估算肾小球滤过率≤20 mL/min/1.73 m²的晚期非透析CKD患者,基线CKD-MBD患病率为94%。甲状旁腺激素(aHR 1.12,95%CI 1.03-1.23,P=.01)和磷酸盐(aHR 1.35,95%CI 1.00-1.84,P=.05)与全因死亡率相关,钙(aHR 1.11,95%CI 0.57-2.17,P=.76)无独立关联但修饰磷酸盐效应。
要点
- 晚期非透析CKD老年患者基线CKD-MBD患病率高达94%。
- PTH与磷酸盐独立关联全因死亡率,钙无独立关联。
- 高钙合并高磷患者死亡风险最高,钙修饰磷酸盐效应。
核心结论
- CKD-MBD在晚期非透析CKD老年患者中非常常见。
- PTH和磷酸盐与该人群全因死亡率独立相关。
- PTH仅与心血管死亡率相关,磷酸盐似乎与心血管和非心血管死亡率均相关。
研究设计与样本
- 研究使用欧洲Quality(EQUAL)研究数据,纳入来自六个欧洲国家的≥65岁、估算肾小球滤过率≤20 mL/min/1.73 m²的患者。
- 采用序贯校正Cox模型评估基线及时间依赖性CKD-MBD生物标志物与全因、心血管和非心血管死亡率之间的关联,并评估生物标志物间的效应修饰。
主要发现
- 在1294例患者中,基线CKD-MBD患病率为94%。
- PTH(校正后风险比aHR 1.12,95%置信区间CI 1.03-1.23,P=.01)和磷酸盐(aHR 1.35,95%CI 1.00-1.84,P=.05)与全因死亡率相关,而钙(aHR 1.11,95%CI 0.57-2.17,P=.76)与全因死亡率无独立关联。
- 钙虽无独立关联,但修饰磷酸盐效应,高钙血症合并高磷酸盐血症患者死亡风险最高。
- PTH水平与心血管死亡率相关,与非心血管死亡率无关;磷酸盐在多数模型中与心血管和非心血管死亡率均相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic kidney disease-mineral and bone disorder (CKD-MBD) is a common complication of CKD; it is associated with higher mortality in dialysis patients, while its impact in non-dialysis patients remains mostly unknown. We investigated the associations between parathyroid hormone (PTH), phosphate and calcium (and their interactions), and all-cause, cardiovascular (CV) and non-CV mortality in older non-dialysis patients with advanced CKD. METHODS: We used data from the European Quality study, which includes patients aged ≥65 years with estimated glomerular filtration rate ≤20 mL/min/1.73 m2 from six European countries. Sequentially adjusted Cox models were used to assess the association between baseline and time-dependent CKD-MBD biomarkers and all-cause, CV and non-CV mortality. Effect modification between biomarkers was also assessed. RESULTS: In 1294 patients, the prevalence of CKD-MBD at baseline was 94%. Both PTH [adjusted hazard ratio (aHR) 1.12, 95% confidence interval (CI) 1.03-1.23, P = .01] and phosphate (aHR 1.35, 95% CI 1.00-1.84, P = .05), but not calcium (aHR 1.11, 95% CI 0.57-2.17, P = .76), were associated with all-cause mortality. Calcium was not independently associated with mortality, but modified the effect of phosphate, with the highest mortality risk found in patients with both hypercalcemia and hyperphosphatemia. PTH level was associated with CV mortality, but not with non-CV mortality, whereas phosphate was associated with both CV and non-CV mortality in most models. CONCLUSIONS: CKD-MBD is very common in older non-dialysis patients with advanced CKD. PTH and phosphate are independently associated with all-cause mortality in this population. While PTH level is only associated with CV mortality, phosphate seems to be associated with both CV and non-CV mortality.
引用
- Magagnoli L, Cozzolino M, Caskey FJ, et al. Association between CKD-MBD and mortality in older patients with advanced CKD-results from the EQUAL study. Nephrol Dial Transplant. 2023. PMID: 37230954. doi:10.1093/ndt/gfad100
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。